Loading…

Surgical Outcomes and Morbidity After Radical Surgery for Ovarian Cancer in Aberdeen Royal Infirmary, the Northeast of Scotland Gynaecologic Oncology Centre

Ovarian cancer (OC) has a high mortality rate and usually presents late in advanced stage, which poses challenges to management. Better understanding of the disease biology and application of radical surgery (RS) to achieve no visible residual tumor, alongside with chemotherapy, may lead to longer s...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2018-02, Vol.38 (2), p.923-928
Main Authors: Kalampokas, Emmanouil, Young, Helena, Bednarek, Antonina, Habib, Mohammad, Parkin, David E, Gurumurthy, Mahalakshmi, Cairns, Mary
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-6ca87524182889b567644188969c2915533d01cb69b3f0fffe9aa7ed8d13c6f93
cites
container_end_page 928
container_issue 2
container_start_page 923
container_title Anticancer research
container_volume 38
creator Kalampokas, Emmanouil
Young, Helena
Bednarek, Antonina
Habib, Mohammad
Parkin, David E
Gurumurthy, Mahalakshmi
Cairns, Mary
description Ovarian cancer (OC) has a high mortality rate and usually presents late in advanced stage, which poses challenges to management. Better understanding of the disease biology and application of radical surgery (RS) to achieve no visible residual tumor, alongside with chemotherapy, may lead to longer survival amongst these patients. Our purpose was to examine the demographic characteristics, surgical morbidity and outcomes of patients undergoing RS for OC. A retrospective cohort study of women undertaking surgery for OC between February 2014 and September 2016 in Aberdeen Royal Infirmary. A total of 121 women had surgery for OC of whom 78 (64.5%) were stage II and above. Of these, 40 (51.3%) women had primary and 38 (48.7%) had interval debulking surgery with 42 (53.8%) having radical surgery. The most common procedures that were performed as part of RS included rectosigmoid resection (n=20, 47.6%), small bowel resection (n=10, 23.8%), splenectomy (n=9, 21.4%). Morbidity outcomes included blood loss >1.5 lt. (n=14, 33.3%), hospitalization >7days (n=31, 73.8%), sepsis (n=8, 19%). There was no short-term mortality. Debulking outcomes were: no macroscopic residual disease (n=36, 85.7%), ≤10 mm disease (n=2, 4.8%), and ≥10 mm disease (n=3, 7.1%). Our findings support the practise where RS for OC can be offered to selected patients, with good surgery outcomes and low morbidity rates.
doi_str_mv 10.21873/anticanres.12304
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1993013702</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2137114680</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-6ca87524182889b567644188969c2915533d01cb69b3f0fffe9aa7ed8d13c6f93</originalsourceid><addsrcrecordid>eNpdkctOHDEQRa2IKAwkH5ANssSGRRr86PZjORrxkggjQbJuud1laNRjg-1G6n_Jx8YzkETKqqqkU7eu6iL0lZJTRpXkZ8bnwRofIZ1Sxkn9AS2o1LSSDSd7aEFYQypJSLOPDlJ6IkQIrfgntM80l7VkbIF-3U_xoWiMeD1lGzaQsPE9_h5iN_RDnvHSZYj4zvQ7aEtDnLELEa9fTRyMxyvjbUEGj5cdxB7A47swF_jauyFuTJy_4fwI-DbEUkzKODh8b0Met5cuZ2_AhjEUF3jtd92MV-BzhM_oozNjgi_v9RD9vDj_sbqqbtaX16vlTWW5ZLkS1ijZsJoqppTuGiFFXQalhbZM06bhvCfUdkJ33BHnHGhjJPSqp9wKp_khOnnTfY7hZYKU282QLIzFIIQptVRrTiiXhBX0-D_0KUzRF3ctKwSltVCkUPSNsjGkFMG1z3HYfqKlpN1F1_6Lrt1FV3aO3pWnbgP9340_WfHfIJaYWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2137114680</pqid></control><display><type>article</type><title>Surgical Outcomes and Morbidity After Radical Surgery for Ovarian Cancer in Aberdeen Royal Infirmary, the Northeast of Scotland Gynaecologic Oncology Centre</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kalampokas, Emmanouil ; Young, Helena ; Bednarek, Antonina ; Habib, Mohammad ; Parkin, David E ; Gurumurthy, Mahalakshmi ; Cairns, Mary</creator><creatorcontrib>Kalampokas, Emmanouil ; Young, Helena ; Bednarek, Antonina ; Habib, Mohammad ; Parkin, David E ; Gurumurthy, Mahalakshmi ; Cairns, Mary</creatorcontrib><description>Ovarian cancer (OC) has a high mortality rate and usually presents late in advanced stage, which poses challenges to management. Better understanding of the disease biology and application of radical surgery (RS) to achieve no visible residual tumor, alongside with chemotherapy, may lead to longer survival amongst these patients. Our purpose was to examine the demographic characteristics, surgical morbidity and outcomes of patients undergoing RS for OC. A retrospective cohort study of women undertaking surgery for OC between February 2014 and September 2016 in Aberdeen Royal Infirmary. A total of 121 women had surgery for OC of whom 78 (64.5%) were stage II and above. Of these, 40 (51.3%) women had primary and 38 (48.7%) had interval debulking surgery with 42 (53.8%) having radical surgery. The most common procedures that were performed as part of RS included rectosigmoid resection (n=20, 47.6%), small bowel resection (n=10, 23.8%), splenectomy (n=9, 21.4%). Morbidity outcomes included blood loss &gt;1.5 lt. (n=14, 33.3%), hospitalization &gt;7days (n=31, 73.8%), sepsis (n=8, 19%). There was no short-term mortality. Debulking outcomes were: no macroscopic residual disease (n=36, 85.7%), ≤10 mm disease (n=2, 4.8%), and ≥10 mm disease (n=3, 7.1%). Our findings support the practise where RS for OC can be offered to selected patients, with good surgery outcomes and low morbidity rates.</description><identifier>ISSN: 0250-7005</identifier><identifier>EISSN: 1791-7530</identifier><identifier>DOI: 10.21873/anticanres.12304</identifier><identifier>PMID: 29374722</identifier><language>eng</language><publisher>Greece: International Institute of Anticancer Research</publisher><subject>Cancer ; Chemotherapy ; Demographics ; Disease control ; Morbidity ; Mortality ; Ovarian cancer ; Patients ; Sepsis ; Small intestine ; Splenectomy ; Surgery ; Surgical outcomes ; Womens health</subject><ispartof>Anticancer research, 2018-02, Vol.38 (2), p.923-928</ispartof><rights>Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</rights><rights>Copyright International Institute of Anticancer Research Feb 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-6ca87524182889b567644188969c2915533d01cb69b3f0fffe9aa7ed8d13c6f93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29374722$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kalampokas, Emmanouil</creatorcontrib><creatorcontrib>Young, Helena</creatorcontrib><creatorcontrib>Bednarek, Antonina</creatorcontrib><creatorcontrib>Habib, Mohammad</creatorcontrib><creatorcontrib>Parkin, David E</creatorcontrib><creatorcontrib>Gurumurthy, Mahalakshmi</creatorcontrib><creatorcontrib>Cairns, Mary</creatorcontrib><title>Surgical Outcomes and Morbidity After Radical Surgery for Ovarian Cancer in Aberdeen Royal Infirmary, the Northeast of Scotland Gynaecologic Oncology Centre</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>Ovarian cancer (OC) has a high mortality rate and usually presents late in advanced stage, which poses challenges to management. Better understanding of the disease biology and application of radical surgery (RS) to achieve no visible residual tumor, alongside with chemotherapy, may lead to longer survival amongst these patients. Our purpose was to examine the demographic characteristics, surgical morbidity and outcomes of patients undergoing RS for OC. A retrospective cohort study of women undertaking surgery for OC between February 2014 and September 2016 in Aberdeen Royal Infirmary. A total of 121 women had surgery for OC of whom 78 (64.5%) were stage II and above. Of these, 40 (51.3%) women had primary and 38 (48.7%) had interval debulking surgery with 42 (53.8%) having radical surgery. The most common procedures that were performed as part of RS included rectosigmoid resection (n=20, 47.6%), small bowel resection (n=10, 23.8%), splenectomy (n=9, 21.4%). Morbidity outcomes included blood loss &gt;1.5 lt. (n=14, 33.3%), hospitalization &gt;7days (n=31, 73.8%), sepsis (n=8, 19%). There was no short-term mortality. Debulking outcomes were: no macroscopic residual disease (n=36, 85.7%), ≤10 mm disease (n=2, 4.8%), and ≥10 mm disease (n=3, 7.1%). Our findings support the practise where RS for OC can be offered to selected patients, with good surgery outcomes and low morbidity rates.</description><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Demographics</subject><subject>Disease control</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Ovarian cancer</subject><subject>Patients</subject><subject>Sepsis</subject><subject>Small intestine</subject><subject>Splenectomy</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Womens health</subject><issn>0250-7005</issn><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkctOHDEQRa2IKAwkH5ANssSGRRr86PZjORrxkggjQbJuud1laNRjg-1G6n_Jx8YzkETKqqqkU7eu6iL0lZJTRpXkZ8bnwRofIZ1Sxkn9AS2o1LSSDSd7aEFYQypJSLOPDlJ6IkQIrfgntM80l7VkbIF-3U_xoWiMeD1lGzaQsPE9_h5iN_RDnvHSZYj4zvQ7aEtDnLELEa9fTRyMxyvjbUEGj5cdxB7A47swF_jauyFuTJy_4fwI-DbEUkzKODh8b0Met5cuZ2_AhjEUF3jtd92MV-BzhM_oozNjgi_v9RD9vDj_sbqqbtaX16vlTWW5ZLkS1ijZsJoqppTuGiFFXQalhbZM06bhvCfUdkJ33BHnHGhjJPSqp9wKp_khOnnTfY7hZYKU282QLIzFIIQptVRrTiiXhBX0-D_0KUzRF3ctKwSltVCkUPSNsjGkFMG1z3HYfqKlpN1F1_6Lrt1FV3aO3pWnbgP9340_WfHfIJaYWg</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Kalampokas, Emmanouil</creator><creator>Young, Helena</creator><creator>Bednarek, Antonina</creator><creator>Habib, Mohammad</creator><creator>Parkin, David E</creator><creator>Gurumurthy, Mahalakshmi</creator><creator>Cairns, Mary</creator><general>International Institute of Anticancer Research</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20180201</creationdate><title>Surgical Outcomes and Morbidity After Radical Surgery for Ovarian Cancer in Aberdeen Royal Infirmary, the Northeast of Scotland Gynaecologic Oncology Centre</title><author>Kalampokas, Emmanouil ; Young, Helena ; Bednarek, Antonina ; Habib, Mohammad ; Parkin, David E ; Gurumurthy, Mahalakshmi ; Cairns, Mary</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-6ca87524182889b567644188969c2915533d01cb69b3f0fffe9aa7ed8d13c6f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Demographics</topic><topic>Disease control</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Ovarian cancer</topic><topic>Patients</topic><topic>Sepsis</topic><topic>Small intestine</topic><topic>Splenectomy</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kalampokas, Emmanouil</creatorcontrib><creatorcontrib>Young, Helena</creatorcontrib><creatorcontrib>Bednarek, Antonina</creatorcontrib><creatorcontrib>Habib, Mohammad</creatorcontrib><creatorcontrib>Parkin, David E</creatorcontrib><creatorcontrib>Gurumurthy, Mahalakshmi</creatorcontrib><creatorcontrib>Cairns, Mary</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kalampokas, Emmanouil</au><au>Young, Helena</au><au>Bednarek, Antonina</au><au>Habib, Mohammad</au><au>Parkin, David E</au><au>Gurumurthy, Mahalakshmi</au><au>Cairns, Mary</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surgical Outcomes and Morbidity After Radical Surgery for Ovarian Cancer in Aberdeen Royal Infirmary, the Northeast of Scotland Gynaecologic Oncology Centre</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>38</volume><issue>2</issue><spage>923</spage><epage>928</epage><pages>923-928</pages><issn>0250-7005</issn><eissn>1791-7530</eissn><abstract>Ovarian cancer (OC) has a high mortality rate and usually presents late in advanced stage, which poses challenges to management. Better understanding of the disease biology and application of radical surgery (RS) to achieve no visible residual tumor, alongside with chemotherapy, may lead to longer survival amongst these patients. Our purpose was to examine the demographic characteristics, surgical morbidity and outcomes of patients undergoing RS for OC. A retrospective cohort study of women undertaking surgery for OC between February 2014 and September 2016 in Aberdeen Royal Infirmary. A total of 121 women had surgery for OC of whom 78 (64.5%) were stage II and above. Of these, 40 (51.3%) women had primary and 38 (48.7%) had interval debulking surgery with 42 (53.8%) having radical surgery. The most common procedures that were performed as part of RS included rectosigmoid resection (n=20, 47.6%), small bowel resection (n=10, 23.8%), splenectomy (n=9, 21.4%). Morbidity outcomes included blood loss &gt;1.5 lt. (n=14, 33.3%), hospitalization &gt;7days (n=31, 73.8%), sepsis (n=8, 19%). There was no short-term mortality. Debulking outcomes were: no macroscopic residual disease (n=36, 85.7%), ≤10 mm disease (n=2, 4.8%), and ≥10 mm disease (n=3, 7.1%). Our findings support the practise where RS for OC can be offered to selected patients, with good surgery outcomes and low morbidity rates.</abstract><cop>Greece</cop><pub>International Institute of Anticancer Research</pub><pmid>29374722</pmid><doi>10.21873/anticanres.12304</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0250-7005
ispartof Anticancer research, 2018-02, Vol.38 (2), p.923-928
issn 0250-7005
1791-7530
language eng
recordid cdi_proquest_miscellaneous_1993013702
source EZB-FREE-00999 freely available EZB journals
subjects Cancer
Chemotherapy
Demographics
Disease control
Morbidity
Mortality
Ovarian cancer
Patients
Sepsis
Small intestine
Splenectomy
Surgery
Surgical outcomes
Womens health
title Surgical Outcomes and Morbidity After Radical Surgery for Ovarian Cancer in Aberdeen Royal Infirmary, the Northeast of Scotland Gynaecologic Oncology Centre
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A00%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surgical%20Outcomes%20and%20Morbidity%20After%20Radical%20Surgery%20for%20Ovarian%20Cancer%20in%20Aberdeen%20Royal%20Infirmary,%20the%20Northeast%20of%20Scotland%20Gynaecologic%20Oncology%20Centre&rft.jtitle=Anticancer%20research&rft.au=Kalampokas,%20Emmanouil&rft.date=2018-02-01&rft.volume=38&rft.issue=2&rft.spage=923&rft.epage=928&rft.pages=923-928&rft.issn=0250-7005&rft.eissn=1791-7530&rft_id=info:doi/10.21873/anticanres.12304&rft_dat=%3Cproquest_cross%3E2137114680%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-6ca87524182889b567644188969c2915533d01cb69b3f0fffe9aa7ed8d13c6f93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2137114680&rft_id=info:pmid/29374722&rfr_iscdi=true